Ctt Pharmaceutical Holdings reported asset growth of 1,787.79% for the quarter ended Sep 2014. These growth metrics cover 17 quarters of results from Sep 2010 through Sep 2014, standardized by Business Quant from the company’s SEC filings.
| Growth MetricsGrowth | Sep2010 | Dec2010 | Mar2011 | Jun2011 | Sep2011 | Dec2011 | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||||||||||
| Share-based Compensation (QoQ)Stock Comp. (QoQ) | 1,158.05% | ||||||||||||||||
| Share-based Compensation Growth (1y)Stock Comp. Growth (1y) | 1,367.38% | ||||||||||||||||
| Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) | 0.00% | ||||||||||||||||
| Operating Income Growth (1y)Op. Inc Growth (1y) | 56.15% | ||||||||||||||||
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | 96.70% | ||||||||||||||||
| Net Income (QoQ) | -31,887.86% | 93.19% | 9,731.05% | -118.96% | 59.01% | 2.77% | -35.48% | 93.89% | -206.28% | -61.69% | 77.05% | -57.50% | 86.70% | 11.64% | 77.65% | 45.01% | -4,595.22% |
| Net Income Growth (3y) | -186.43% | 78.62% | 49.77% | -26.00% | 90.52% | 53.94% | |||||||||||
| Net Income Growth (1y) | -39,684.88% | 49.02% | -627.71% | -110.24% | 96.70% | 75.35% | 59.00% | 93.05% | -79.03% | 92.23% | 95.75% | 95.86% | 98.56% | -409.81% | |||
| Net Cash Flow (QoQ)NCF (QoQ) | -133.76% | 82.86% | 305.53% | 17.76% | -134.47% | 17.73% | -192.99% | 89.84% | -171.26% | 77.86% | 129.21% | -260.43% | 41.45% | -73.62% | 393.37% | 536.25% | 15.05% |
| Net Cash Flow Growth (3y)NCF Growth (3y) | 71.54% | 82.06% | 61.18% | -56.30% | -23.31% | 51.91% | |||||||||||
| Net Cash Flow Growth (1y)NCF Growth (1y) | 196.96% | 85.70% | 31.37% | -197.84% | -108.44% | 33.55% | 82.11% | 101.78% | 71.85% | 93.92% | 52.36% | 378.46% | 1,997.55% | 3,828.61% | |||
| Income After Tax Growth (1y) | 55.57% | ||||||||||||||||
| Free Cash Flow (QoQ)FCF (QoQ) | -255.49% | 76.68% | 95.20% | 4,148.03% | -134.47% | 224.69% | -409.10% | 57.79% | 40.12% | 42.89% | 17.61% | 54.02% | 28.01% | -458.70% | 99.76% | -8,608.18% | 15.76% |
| Free Cash Flow Growth (3y)FCF Growth (3y) | 51.09% | 71.28% | 17.20% | 69.40% | -27.27% | 46.80% | |||||||||||
| Free Cash Flow Growth (1y)FCF Growth (1y) | 261.05% | 84.38% | 183.51% | -5,277.61% | -156.08% | 2.58% | -144.61% | 88.11% | 87.05% | 84.43% | -52.35% | 99.55% | 15.16% | 0.72% | |||
| EPS (Diluted) Growth (1y) | 96.85% | ||||||||||||||||
| EPS (Basic) Growth (1y) | 96.85% | ||||||||||||||||
| EBT Growth (1y) | 55.57% | ||||||||||||||||
| EBIT Growth (1y) | 56.15% | ||||||||||||||||
| Cash from Operations (QoQ)Cash from Ops. (QoQ) | -255.49% | 76.68% | 95.20% | 4,148.03% | -134.47% | 224.69% | -359.20% | 49.66% | 40.12% | 42.89% | 17.61% | 54.02% | 28.01% | -458.70% | 99.76% | -8,608.18% | 15.76% |
| Cash from Operations Growth (3y)Cash from Ops. Growth (3y) | 51.09% | 71.28% | 17.20% | 69.40% | -27.27% | 46.80% | |||||||||||
| Cash from Operations Growth (1y)Cash from Ops. Growth (1y) | 261.05% | 84.38% | 183.51% | -4,409.56% | -156.08% | 2.58% | -144.61% | 85.82% | 87.05% | 84.43% | -52.35% | 99.55% | 15.16% | 0.72% | |||
| Cash from Investing Activities (QoQ)Cash from Investing (QoQ) | 122.09% | 125.96% | -77.59% | 32.14% | 22.52% | -71.72% | -21.48% | 598.38% | -77.18% | -617.99% | 283.54% | ||||||
| Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y) | -58.79% | ||||||||||||||||
| Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) | -75.88% | 114.78% | -18.03% | -89.74% | -64.05% | 90.01% | -64.62% | -748.13% | 1,414.94% | ||||||||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | 757.34% | 117.76% | -18.64% | -18.85% | -68.05% | -21.64% | -74.93% | -58.34% | 1,783.92% | -43.58% | |||||||
| Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) | -69.01% | -36.37% | -43.68% | ||||||||||||||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 1,132.66% | -54.06% | -83.47% | -94.91% | -89.56% | -94.45% | -37.95% | 2,705.89% | |||||||||
| Assets (QoQ) | -68.22% | -52.56% | -45.08% | -41.37% | -80.70% | -63.21% | -51.96% | 1,221.46% | -42.54% | ||||||||
| Assets Growth (1y) | -95.15% | -97.05% | -97.71% | -98.00% | -56.06% | 1,478.41% | 1,787.79% |
Pull Ctt Pharmaceutical Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CTTH&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CTTH", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CTTH&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();